• Fri, February 17, 2023

by: WOPRAI

Joshua Reilly Maintained (TYL) at Strong Buy and Held Target at $475 on, Feb 17th, 2023

by: WOPRAI

Rob Oliver Maintained (TYL) at Buy and Held Target at $440 on, Feb 17th, 2023

by: WOPRAI

Joe Goodwin Maintained (TYL) at Buy and Held Target at $415 on, Feb 17th, 2023

by: WOPRAI

Alex Zukin Maintained (TYL) at Buy with Increased Target to $365 on, Feb 17th, 2023

by: WOPRAI

Ed Arce Reiterated (TVTX) at Strong Buy and Held Target at $36 on, Feb 17th, 2023

by: WOPRAI

Kenneth Lee Maintained (TWO) at Hold with Increased Target to $17 on, Feb 17th, 2023

by: WOPRAI

Ygal Arounian Maintained (TTD) at Strong Buy with Increased Target to $76 on, Feb 17th, 2023

by: WOPRAI

Christopher Danely Maintained (ADI) at Strong Buy with Increased Target to $225 on, Feb 17th, 2023

by: WOPRAI

Matthew Hedberg Maintained (ADSK) at Buy with Increased Target to $250 on, Feb 17th, 2023

by: WOPRAI

Neil Kalton Maintained (AEE) at Buy with Decreased Target to $97 on, Feb 17th, 2023

by: WOPRAI

Samuel Bland Upgraded (ZIM) to Buy and Increased Target to $30 on, Feb 17th, 2023

by: WOPRAI

Ygal Arounian Maintained (ZD) at Hold with Decreased Target to $90 on, Feb 17th, 2023

by: WOPRAI

James Ricchiuti Maintained (ZBRA) at Strong Buy with Increased Target to $385 on, Feb 17th, 2023

by: WOPRAI

Mike Burton Maintained (Z) at Hold with Increased Target to $36 on, Feb 17th, 2023

by: WOPRAI

Ronald Josey Maintained (Z) at Strong Buy with Increased Target to $59 on, Feb 17th, 2023

by: WOPRAI

Mike Burton Maintained (ZG) at Hold with Increased Target to $36 on, Feb 17th, 2023

by: WOPRAI

Ronald Josey Maintained (ZG) at Strong Buy with Increased Target to $59 on, Feb 17th, 2023

by: WOPRAI

Brian Vaccaro Maintained (BLMN) at Strong Buy with Increased Target to $33 on, Feb 17th, 2023

by: WOPRAI

Lauren Silberman Maintained (BLMN) at Buy with Increased Target to $31 on, Feb 17th, 2023

by: WOPRAI

Jeffrey Bernstein Maintained (BLMN) at Buy with Increased Target to $31 on, Feb 17th, 2023

by: WOPRAI

Jon Tower Maintained (BLMN) at Hold with Increased Target to $29 on, Feb 17th, 2023

by: WOPRAI

Dan Leonard Maintained (BIO) at Buy with Increased Target to $680 on, Feb 17th, 2023

by: WOPRAI

Conor McNamara Maintained (BIO) at Buy with Increased Target to $579 on, Feb 17th, 2023

by: WOPRAI

Joshua Long Reiterated (BJRI) at Hold and Held Target at $27 on, Feb 17th, 2023

by: WOPRAI

Nick Setyan Maintained (BJRI) at Hold with Increased Target to $36 on, Feb 17th, 2023

by: WOPRAI

David Tarantino Maintained (BJRI) at Hold with Increased Target to $32 on, Feb 17th, 2023

by: WOPRAI

Brian Bittner Maintained (BJRI) at Buy with Increased Target to $40 on, Feb 17th, 2023

by: WOPRAI

Douglas Tsao Reiterated (CABA) at Strong Buy and Held Target at $11 on, Feb 17th, 2023

by: WOPRAI

Charles Shi Maintained (CAMT) at Strong Buy with Increased Target to $40 on, Feb 17th, 2023

by: WOPRAI

Tom O"Malley Maintained (CAMT) at Hold with Increased Target to $28 on, Feb 17th, 2023

by: WOPRAI

Craig Ellis Maintained (CAMT) at Hold with Increased Target to $30 on, Feb 17th, 2023

by: WOPRAI

Joseph Stringer Reiterated (CARA) at Strong Buy and Held Target at $26 on, Feb 17th, 2023

by: WOPRAI

Daniel Ford Maintained (AWK) at Hold with Decreased Target to $154 on, Feb 17th, 2023

by: WOPRAI

PJ Juvekar Maintained (AVNT) at Strong Buy with Increased Target to $48 on, Feb 17th, 2023

by: WOPRAI

George Gianarikas Maintained (ASPN) at Strong Buy with Decreased Target to $18 on, Feb 17th, 2023

by: WOPRAI

Tiago Fauth Reiterated (ASND) at Buy and Held Target at $130 on, Feb 17th, 2023

by: WOPRAI

Vikram Purohit Maintained (ASND) at Buy with Increased Target to $151 on, Feb 17th, 2023

by: WOPRAI

Kate McShane Maintained (ASO) at Strong Buy with Increased Target to $72 on, Feb 17th, 2023

by: WOPRAI

Tim Nollen Downgraded (APPS) to Hold and Held Target at $12 on, Feb 17th, 2023

by: WOPRAI

Thomas Blakey Maintained (APPN) at Buy with Increased Target to $55 on, Feb 17th, 2023

by: WOPRAI

Joseph Meares Maintained (APPN) at Strong Buy with Increased Target to $50 on, Feb 17th, 2023

by: WOPRAI

Sanjit Singh Maintained (APPN) at Hold with Increased Target to $46 on, Feb 17th, 2023

by: WOPRAI

Lucas Pipes Maintained (ARCH) at Strong Buy with Decreased Target to $204 on, Feb 17th, 2023

by: WOPRAI

Neal Dingmann Maintained (AR) at Strong Buy with Decreased Target to $34 on, Feb 17th, 2023

by: WOPRAI

Christopher Zhang Initiated (WIX) at Buy and Held Target at $105 on, Feb 17th, 2023

by: WOPRAI

Michael Swartz Maintained (WGO) at Strong Buy with Increased Target to $76 on, Feb 17th, 2023

by: WOPRAI

Kurt Hallead Initiated (WFRD) at Strong Buy and Held Target at $88 on, Feb 17th, 2023

by: WOPRAI

Gary Nachman Downgraded (VTRS) to Hold and Decreased Target to $14 on, Feb 17th, 2023

Paul Knight Maintained (WST) at Buy with Increased Target to $375 on, Feb 17th, 2023

Paul Knight of Keybanc, Maintained "West Pharmaceutical Services, Inc." (WST) at Buy with Increased Target from $315 to $375 on, Feb 17th, 2023.

Paul has made no other calls on WST in the last 4 months.



There are 3 other peers that have a rating on WST. Out of the 3 peers that are also analyzing WST, all agree with Paul's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Justin Bowers of "Deutsche Bank" Initiated at Hold and Held Target at $250 on, Wednesday, December 14th, 2022
  • John Sourbeer of "UBS" Initiated at Hold and Held Target at $250 on, Wednesday, November 30th, 2022
  • Derik De Bruin of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $250 on, Friday, October 28th, 2022

Like: 👍